FDA Investigator Anthony R Bucks
Anthony R Bucks has conducted inspections on 37 sites in 1 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
37
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Anthony R Bucks:
Adree N Anderson,
Alan L Brend,
Alan L Truong,
Alex M Viehmann,
Amir A Abdalla,
Amy E Devine,
Ana Paulap Sandee,
Andrew A Hoopes,
April K Hill,
Aref Mel Demerdash,
Ashley A Mutawakkil,
Audrey N Vigil,
Barbara I Rogolsky,
Beatrix D Arevalo,
Beatrix D Hippe,
Blondell W Johnson,
Brenda C Hamilton,
Brent T Hall,
Brett R Havranek,
Brittany D Terhar,
Bryan S Roddy,
Candace S Tucker,
Carl A Huffman, III,
Ceisha C Ukatu,
Chih Jung Hsu, PhD,
Chilton L Ng,
Christine A Harman, PhD,
Cody D Rickman,
Cody J Alley,
Cynthia L Evitt,
Cynthia M Goudeau,
Damaris Y Hernandez,
Danial S Hutchison,
Daniel R Hurt,
Darrah,
David J Eide,
David L Miser,
Dawn C Olenjack,
Dewayne E Whitlock,
Dina K West,
Donald L Myers,
Edward E Lockwood (EEL),
Elmina E Mboh,
Emilio O Escobar,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric M Padgett,
Erika V Butler,
Farhana Khan,
Frank Wackes,
Georgia A Layloff,
Gloria J Champagne,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Hector A Carrero,
Helen Y Saccone,
Hongjian Ding,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James D Planchon,
James I Giefer,
Janet B Abt,
Janna C Hutchinson,
Jason H Wieners,
Jazmine N Still,
Jeannie M Vonderbrink,
Jeffery A Hangartner,
Jeffery L Sumter,
Jennifer Cahill,
Jill J Tillman,
John C Mcmichael,
Johnson,
Jonathan G Gayechuway,
Jonathan R Campos,
Joohi Castelvetere,
Joseph A Piechocki,
Joseph R Lambert,
Joseph R Strelnik,
Juandria V Williams,
Justin A Boyd,
Kara L Roden,
Karen C Daugherty,
Karen M Cruz Arenas,
Karen M Montgomery (KMM),
Karthik B Iyer,
Kathleen B Swat,
Kathleen M Bradley,
Kellia N Hicks,
Kelly D Sheppard,
Kelly K Nachtigal,
Ken L Bowers,
Kendra A Biddick,
Kevin D Kallander,
Kshitij A Patkar,
LCDR Matthew J Morrison,
Lewis K Antwi,
Linda K Cline,
Lisa L Flores,
Lisa L Gilliam,
Margaret A Smithers,
Mark S Ross,
Mary K Concannon,
Mary L Schuckmann,
Matthew H Hunt,
Matthew M Schuckmann,
Matthew Ondeck,
Matthew R Sleeter,
Megan M Kirk,
Meisha Waters,
Michael D Porter,
Michele L Obert,
Michele Perry Williams,
Minerva Rogers,
Monica Cburgos Garcia,
Monica E Murie,
Monica M Mcclure,
Nancy G Schmidt,
Neal L Adams,
Omotunde O Osunsanmi,
Pamela L Velez Vega,
Patrick L Wisor,
Paula A Trost,
Peng Zhou,
Philip J Boston,
Phillip M Pontikos,
Rachel Collen,
Ralph H Vocque,
Raymond Valdivia,
Rebecca Rodriguez,
Richard L Rutherford,
Rick L Friedman,
Rita K Kabaso,
Robert J Ham,
Robin K Hatfield,
Robin K Reel,
Rohit B Kolhatkar,
Samuel K Gibbons, Jr,
Sandra A Boyd,
Sandra A Hughes,
Sarah E Rhoades,
Scott A Golladay,
Scott A Jepson,
Shafiq S Ahadi,
Shanna R Haden,
Sharon K Thoma, PharmD,
Sherry G Bous,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sina Shojaee,
Steven D Kehoe,
Steven P Donald,
Susan M Jackson,
Susanna E Ford,
Tamara J Umscheid,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Tonya R Johnson,
Torrey M Ward,
Trevor A Parker,
Verlinda A Narcisse,
Veronica L Call,
Victoria A Wagoner,
Walsworth,
Warren J Lopicka,
Wayne D Mcgrath,
William C Corley,
William Hallett, PhD,
Zachary A Bogorad,
Zedong Dong,
Zhong Li, PhD,
Zi Qiang Gu
Anthony R Bucks's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more